Vir Biotechnology, Inc. (VIR) revenue

Revenue · fiscal 2025
$66.52M

Vir Biotechnology, Inc. (VIR) reported revenue of $66.52M in fiscal 2025 (the year ended December 31, 2025). That is 4.4% higher than the $63.71M of fiscal 2024. Figures as of 18 Nov 2026, 11:43 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$66.52M
Change on fiscal 2024
+4.4%
Growth, 5 years
−2.7% a year
Highest on record
$1.58Bfiscal 2022
Lowest on record
$2.71Mfiscal 2017
Fiscal years on record
92017–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Vir Biotechnology, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue shrank at a compound 2.7% a year. Across the 9 fiscal years on record (2017–2025), the highest was $1.58B in fiscal 2022 and the lowest $2.71M in fiscal 2017.

History · 9 fiscal years

Revenue by fiscal year

Vir Biotechnology, Inc. revenue, year by year

Vir Biotechnology, Inc. (VIR) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$66.52M 4.4% up
2024$63.71M 61.3% up
2023$39.49M 97.5% down
2022$1.58B 44.3% up
2021$1.10B 1,334.4% up
2020$76.37M 843.9% up
2019$8.09M 24.2% down
2018$10.67M 293.9% up
2017$2.71M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on VIR

Vir Biotechnology, Inc., figure by figure

Vir Biotechnology, Inc. (VIR) overview: price, valuation and scorecard

Vir Biotechnology, Inc. revenue: questions and answers

What is Vir Biotechnology, Inc.'s revenue?

Vir Biotechnology, Inc. (VIR) reported revenue of $66.52M in fiscal 2025 (the year ended December 31, 2025). That is 4.4% higher than the $63.71M of fiscal 2024.

What is the growth rate of Vir Biotechnology, Inc.'s revenue?

Over the five fiscal years to 2025 revenue shrank at a compound 2.7% a year.

What are the highest and lowest revenue figures on record for Vir Biotechnology, Inc.?

Across the 9 fiscal years on record (2017–2025), the highest was $1.58B in fiscal 2022 and the lowest $2.71M in fiscal 2017.

How is Vir Biotechnology, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Vir Biotechnology, Inc. it is on record here for 9 fiscal years, 2017 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Vir Biotechnology, Inc. (VIR) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/VIR/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.